Ensysce Biosciences (ENSC) Competitors $2.43 -0.11 (-4.33%) Closing price 04:00 PM EasternExtended Trading$2.50 +0.07 (+2.88%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ENSC vs. PASG, MIRA, ENLV, MBRX, XCUR, FBLG, SNYR, MTVA, NEUP, and ALLRShould you be buying Ensysce Biosciences stock or one of its competitors? The main competitors of Ensysce Biosciences include Passage Bio (PASG), MIRA Pharmaceuticals (MIRA), Enlivex Therapeutics (ENLV), Moleculin Biotech (MBRX), Exicure (XCUR), FibroBiologics (FBLG), Synergy CHC (SNYR), MetaVia (MTVA), Neuphoria Therapeutics (NEUP), and Allarity Therapeutics (ALLR). These companies are all part of the "pharmaceutical products" industry. Ensysce Biosciences vs. Its Competitors Passage Bio MIRA Pharmaceuticals Enlivex Therapeutics Moleculin Biotech Exicure FibroBiologics Synergy CHC MetaVia Neuphoria Therapeutics Allarity Therapeutics Ensysce Biosciences (NASDAQ:ENSC) and Passage Bio (NASDAQ:PASG) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, valuation, dividends, profitability, risk, earnings, analyst recommendations and institutional ownership. Which has more risk & volatility, ENSC or PASG? Ensysce Biosciences has a beta of 1.1, meaning that its share price is 10% more volatile than the S&P 500. Comparatively, Passage Bio has a beta of 1.81, meaning that its share price is 81% more volatile than the S&P 500. Do insiders and institutionals hold more shares of ENSC or PASG? 5.6% of Ensysce Biosciences shares are owned by institutional investors. Comparatively, 53.5% of Passage Bio shares are owned by institutional investors. 7.9% of Ensysce Biosciences shares are owned by insiders. Comparatively, 4.3% of Passage Bio shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Is ENSC or PASG more profitable? Passage Bio has a net margin of 0.00% compared to Ensysce Biosciences' net margin of -88.76%. Passage Bio's return on equity of -103.87% beat Ensysce Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Ensysce Biosciences-88.76% -167.23% -104.59% Passage Bio N/A -103.87%-59.95% Does the media prefer ENSC or PASG? In the previous week, Ensysce Biosciences and Ensysce Biosciences both had 1 articles in the media. Ensysce Biosciences' average media sentiment score of 1.00 beat Passage Bio's score of 0.00 indicating that Ensysce Biosciences is being referred to more favorably in the media. Company Overall Sentiment Ensysce Biosciences Positive Passage Bio Neutral Do analysts recommend ENSC or PASG? Passage Bio has a consensus price target of $75.67, suggesting a potential upside of 854.18%. Given Passage Bio's stronger consensus rating and higher possible upside, analysts plainly believe Passage Bio is more favorable than Ensysce Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ensysce Biosciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Passage Bio 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 Which has better earnings & valuation, ENSC or PASG? Ensysce Biosciences has higher revenue and earnings than Passage Bio. Ensysce Biosciences is trading at a lower price-to-earnings ratio than Passage Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEnsysce Biosciences$5.21M1.39-$7.99M-$4.03-0.60Passage BioN/AN/A-$64.77M-$18.16-0.44 SummaryPassage Bio beats Ensysce Biosciences on 9 of the 14 factors compared between the two stocks. Get Ensysce Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ENSC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ENSC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ENSC vs. The Competition Export to ExcelMetricEnsysce BiosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.54M$3.35B$6.15B$10.62BDividend YieldN/A2.28%5.64%4.69%P/E Ratio-0.6022.1685.6627.13Price / Sales1.39266.37527.36205.87Price / CashN/A46.3226.3031.10Price / Book0.949.9612.926.67Net Income-$7.99M-$52.42M$3.30B$276.23M7 Day Performance3.85%5.95%4.80%3.31%1 Month Performance14.08%11.59%8.11%10.76%1 Year Performance-27.52%25.01%75.85%33.58% Ensysce Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ENSCEnsysce Biosciences0.8203 of 5 stars$2.43-4.3%N/A-24.2%$7.54M$5.21M-0.6010Positive NewsShort Interest ↓Gap UpHigh Trading VolumePASGPassage Bio3.3188 of 5 stars$8.14+1.8%$75.67+829.6%-38.8%$25.43MN/A-0.45130News CoverageGap UpMIRAMIRA Pharmaceuticals0.5533 of 5 stars$1.33+0.8%N/A+17.4%$25.17MN/A-2.712Analyst UpgradeENLVEnlivex Therapeutics2.7834 of 5 stars$1.01-1.9%$10.00+890.1%-33.3%$25.02MN/A-1.7470MBRXMoleculin Biotech3.0462 of 5 stars$0.49-1.0%$4.00+721.5%-80.4%$24.35MN/A0.0020Analyst DowngradeXCURExicure1.7564 of 5 stars$3.90+2.4%N/A+54.4%$24.07M$500K-1.0150News CoveragePositive NewsFBLGFibroBiologics1.9725 of 5 stars$0.61+6.7%$12.67+1,969.7%-80.7%$24.03MN/A-1.7010SNYRSynergy CHC3.9051 of 5 stars$2.41-3.6%$10.00+314.9%-37.5%$23.60M$34.83M6.3440MTVAMetaVia2.3971 of 5 stars$0.94-2.9%$7.50+696.5%N/A$23.47MN/A0.008Positive NewsGap DownNEUPNeuphoria Therapeutics2.2471 of 5 stars$11.86-3.7%$28.00+136.1%N/A$23.14M$15.66M0.00N/AEarnings ReportShort Interest ↓ALLRAllarity Therapeutics2.6982 of 5 stars$1.59+0.6%$9.25+481.8%-11.9%$23.10MN/A0.0010 Related Companies and Tools Related Companies PASG Alternatives MIRA Alternatives ENLV Alternatives MBRX Alternatives XCUR Alternatives FBLG Alternatives SNYR Alternatives MTVA Alternatives NEUP Alternatives ALLR Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ENSC) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A Millionaire With SEVEN Clicks? $1,000 in just seven stocks in 2004 could have turned into a million-dolla...The Oxford Club | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWarren Buffett’s #1 AI Stock is Not Even on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ensysce Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ensysce Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
